Evaluation in Cardiac Rehabilitation: Traditional Review

Öz

Objective: A comprehensive evaluation is required in order to plan an individual rehabilitation program in cardiac diseases. The assessment should be structured to examine the patient's cardiac disease-specific symptoms in different dimensions. The aim of this study is to review components of the evaluation which is implemented in the cardiac rehabilitation program.
Method: In the scope of this review PubMed, Scopus ve Google scholar databases were searched. After selecting 44 articles that met the inclusion criteria of the study, other studies were excluded.
Results: Evaluation in cardiac rehabilitation should consist of these components: cardiac disease epicrisis, anamnesis, inspection, palpation, evaluation of body composition, ECG findings, rhythm evaluation, echocardiography, auscultation, laboratory findings, respiratory evaluation, cardiac rehabilitation outcome measures, comorbidity evaluation, functional evaluations, physical activity level evaluation, other assessments (sleep quality, fatigue, psychosocial status, activities of daily living, disease-specific patient self-reported scales, health-related quality of life, compliance with the exercise program, etc.) and assessment according to the ICF biopsychosocial model. It is also very important to analyze and report the evaluation results. It should be noted that assessment in cardiac rehabilitation is one of the components of Phase I cardiac rehabilitation. Evaluation results can be used to demonstrate the individual success and effectiveness of the program in cardiac rehabilitation. Evaluation is necessary to objectively demonstrate to the patient and other members of the multidisciplinary team the improvements achieved in the rehabilitation program.
Conclusion: In cardiac rehabilitation, it is necessary to make appropriate evaluations for the cardiac rehabilitation phases in order to know the symptoms specific to the disease and to determine the physical, physiological, and functional level of the patient. By interpreting the evaluation results, a suitable cardiac rehabilitation program can be planned for the patient.

Anahtar Kelimeler

• cardiac disease
• biopsychosocial model
• assessment
• Phase I cardiac rehabilitation

Proje Numarası

2211-A Genel Yurtiçi Doktora Burs Programı

Kardiyak Rehabilitasyonda Değerlendirme: Geleneksel Derleme

Öz

Amaç: Kardiyak hastalıklarda kişiye uygun bir rehabilitasyon programının planlanabilmesi i̇çin kapsamlı bir değerlendirme yapılması gerekmektedir. Değerlendirme hastanın kardiyak hastalığa özgü semptomlarını farklı boyutlarda i̇nceleyecek biçimde yapılandırılmalıdır. Bu çalışmanın amacı kardiyak rehabilitasyonda uygulanan değerlendirme programının bileşenlerinin derlenmesidir.
Gereç ve Yöntem: Bu derleme kapsamında PubMed, Scopus ve Google akademik veritabanları taranmıştır. Çalışmanın dahil edilme kriterlerine uygun olan 44 makale seçilerek diğer çalışmalar dışlanmıştır.
Bulgular: Kardiyak rehabilitasyonda değerlendirme kardiyak hastalık epikrizi, anamnez, inspeksiyon, palpasyon, vücut kompozisyonunun değerlendirilmesi, EKG bulguları, ritim değerlendirmesi, ekokardiyografi, oskültasyon, laboratuvar bulguları, solunum değerlendirmesi, kardiyak rehabilitasyon sonuç ölçümleri, komorbidite değerlendirmesi, fonksiyonel değerlendirmeler, fiziksel aktivite düzeyi değerlendirmesi, diğer değerlendirmeler (uyku kalitesi, yorgunluk, psikososyal durum, günlük yaşam aktiviteleri, hastalığa özgü hasta bildirimi ölçekleri, sağlıkla ilişkili yaşam kalitesi, egzersiz programına uyum vb.) ve ICF biyopsikososyal modeline göre değerlendirme bileşenlerini içermelidir. Ayrıca değerlendirme sonuçlarının analizi ve raporlanması da oldukça önemlidir. Kardiyak rehabilitasyonda değerlendirmenin kardiyak rehabilitasyon Faz 1 evresinin bileşenlerinden biri olduğu unutulmamalıdır. Kardiyak rehabilitasyonda değerlendirme sonuçları bireysel başarıyı ve programın etkinliğini göstermede kullanılabilir. Değerlendirme, hastaya ve multidisipliner ekibin diğer üyelerine rehabilitasyon programıyla hastada elde edilen gelişmeleri objektif olarak kanıtlayabilmek için gereklidir.
Sonuç: Kardiyak rehabilitasyonda hastalığa özgü semptomların bilinmesi ve hastanın fiziksel, fizyolojik, fonksiyonel düzeyinin belirlenmesi amacıyla kardiyak rehabilitasyon fazlarına uygun değerlendirmelerin yapılması gerekmektedir. Değerlendirme sonuçları yorumlanarak hastaya uygun kardiyak rehabilitasyon programı planlanabilir.

Anahtar Kelimeler

• kardiyak hastalık
• biyopsikososyal model
• değerlendirme
• kardiyak rehabilitasyon Faz I

Destekleyen Kurum

TÜBİTAK BİDEB

Proje Numarası

2211-A Genel Yurtiçi Doktora Burs Programı

Teşekkür

Bu çalışmaya 2211-A Genel Yurtiçi Doktora Burs Programı kapsamında finansal destek sağlayan TÜBİTAK BİDEB’e teşekkürlerimi sunarım.

Kaynakça

1. 2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. (2011). Journal of the American College of Cardiology, 57(19), 1920–1959.
2. ACSM’s Guidelines for Exercise Testing and Prescription | American College of Sports Medicine | Wolters Kluwer. (n.d.). Retrieved May 31, 2022, from https://www.wolterskluwer.com/en/know/acsm/guidelines-for-exercise-testing-and-prescription?src=Advertisement&cid=&utm_source=google&utm_medium=Max&utm_campaign=&gclid=Cj0KCQjw-daUBhCIARIsALbkjSbRAyYqEZRdi8qJUlgqw1Nc9E9r2fwdiRahkeh6pX8lWiFLtkTE3toaAgp0EALw_wcB
3. American Association of Cardiovascular & Pulmonary Rehabilitation. (n.d.). Guidelines for cardiac rehabilitation and secondary prevention programs.
4. Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., Michos, E. D., Miedema, M. D., Muñoz, D., Smith, S. C. J., Virani, S. S., Williams, K. A. S., Yeboah, J., & Ziaeian, B. (2019). 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 140(11), e596–e646.
5. Arnold, N., Lechner, K., Waldeyer, C., Shapiro, M. D., & Koenig, W. (2021). Inflammation and Cardiovascular Disease: The Future. European Cardiology, 16, e20. https://doi.org/10.15420/ecr.2020.50
6. Ashley, E. A., & Niebauer, J. (2004). Understanding the echocardiogram. In Cardiology explained. Remedica.
7. ATS statement: guidelines for the six-minute walk test. (2002). American Journal of Respiratory and Critical Care Medicine, 166(1), 111–117. https://doi.org/10.1164/ajrccm.166.1.at1102
8. Bösner, S., Haasenritter, J., Becker, A., Karatolios, K., Vaucher, P., Gencer, B., Herzig, L., Heinzel-Gutenbrunner, M., Schaefer, J. R., Abu Hani, M., Keller, H., Sönnichsen, A. C., Baum, E., & Donner-Banzhoff, N. (2010). Ruling out coronary artery disease in primary care: development and validation of a simple prediction rule. CMAJ : Canadian Medical Association Journal = Journal de l’Association Medicale Canadienne, 182(12), 1295–1300. https://doi.org/10.1503/cmaj.100212

9. Buckley, B., & Murphy, A. W. (2009). Do patients with angina alone have a more benign prognosis than patients with a history of acute myocardial infarction, revascularisation or both? Findings from a community cohort study. Heart, 95(6), 461–467. https://doi.org/10.1136/HRT.2008.146944
10. Buckley, B. S., Simpson, C. R., McLernon, D. J., Murphy, A. W., & Hannaford, P. C. (2009). Five year prognosis in patients with angina identified in primary care: incident cohort study. BMJ, 339(7718), 438–441. https://doi.org/10.1136/BMJ.B3058
11. Campeau, L. (2002). The Canadian Cardiovascular Society grading of angina pectoris revisited 30 years later. The Canadian Journal of Cardiology, 18(4), 371–379.
12. Chang, A. M., Fischman, D. L., & Hollander, J. E. (2017). Evaluation of Chest Pain and Acute Coronary Syndromes. Cardiology Clinics, 36(1), 1–12. https://neuro.unboundmedicine.com/medline/citation/29173670/Evaluation_of_Chest_Pain_and_Acute_Coronary_Syndromes_
13. Chow, S. L., Sasson, C., Benjamin, I. J., Califf, R. M., Compton, W. M., Oliva, E. M., Robson, C., & Sanchez, E. J. (2021). Opioid Use and Its Relationship to Cardiovascular Disease and Brain Health: A Presidential Advisory from the American Heart Association. Circulation, 144, E218–E232. https://doi.org/10.1161/CIR.0000000000001007
14. Chrysant, S. G. (2011). A new paradigm in the treatment of the cardiovascular disease continuum: focus on prevention. Hippokratia, 15(1), 7–11.
15. Clark, A. L., & Cleland, J. G. F. (2013). Causes and treatment of oedema in patients with heart failure. Nature Reviews. Cardiology, 10(3), 156–170. https://doi.org/10.1038/nrcardio.2012.191
16. Clini, E. M., & Crisafulli, E. (2009). Exercise capacity as a pulmonary rehabilitation outcome. Respiration; International Review of Thoracic Diseases, 77(2), 121–128. https://doi.org/10.1159/000192773
17. D’Hoore, W., Bouckaert, A., & Tilquin, C. (1996). Practical considerations on the use of the Charlson comorbidity index with administrative data bases. Journal of Clinical Epidemiology, 49(12), 1429–1433. https://doi.org/10.1016/s0895-4356(96)00271-5
18. Durazzo, M., Gargiulo, G., & Pellicano, R. (2018). Non-cardiac chest pain: a 2018 update. Minerva Cardioangiologica, 66(6), 770–783. https://www.unboundmedicine.com/medline/citation/29642692/Non_cardiac_chest_pain:_a_2018_update_
19. Enas, E. A., Varkey, B., Dharmarajan, T. S., Pare, G., & Bahl, V. K. (2019). Lipoprotein(a): An independent, genetic, and causal factor for cardiovascular disease and acute myocardial infarction. Indian Heart Journal, 71(2), 99–112. https://doi.org/10.1016/j.ihj.2019.03.004
20. Ferrazza, A. M., Martolini, D., Valli, G., & Palange, P. (2009). Cardiopulmonary exercise testing in the functional and prognostic evaluation of patients with pulmonary diseases. Respiration; International Review of Thoracic Diseases, 77(1), 3–17. https://doi.org/10.1159/000186694
21. Fihn, S. D., Blankenship, J. C., Alexander, K. P., … Shen, W. K. (2014). 2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation, 130(19), 1749–1767.
22. Frey, S. M., & Zellweger, M. J. (2020). [A heart murmur - a frequent incidental finding]. Therapeutische Umschau. Revue therapeutique, 77(8), 349–356. https://doi.org/10.1024/0040-5930/a001203
23. E., Şen, S., Aslan, F. E., Hemşirelik, S. Ü., & Dalı, A. (2015). The Factors Effecting Capillary Refill Time. Journal of Contemporary Medicine, 5. https://doi.org/10.16899/CTD.91371
24. Hunt, S. A., Baker, D. W., Chin, M. H., Cinquegrani, M. P., … Smith, S. C. J. (2001). ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guide. Journal of the American College of Cardiology, 38(7), 2101–2113.
25. Kaminsky, L. A. (2006). ACSM’s resource manual : for guidelines for exercise testing and prescription (Fifth ed.). Lippincott Williams & Wilkins.
26. Kocabaş, A., Atış, S., Çöplü, L., Erdinç, E., Ergan, B., Gürgün, A., Köktürk, N., Polatlı, M., Şen, E., & Yıldırım, N. (2014). Kronik obstrüktif akciğer hastaliği (KOAH) koruma, tani ve tedavi raporu 2014. Official Journal of the Turkish Thoracic Society, 15(2), 1–72.
27. Kronenberg, F. (2016). Human Genetics and the Causal Role of Lipoprotein(a) for Various Diseases. Cardiovascular Drugs and Therapy, 30(1), 87–100. https://doi.org/10.1007/s10557-016-6648-3
28. Lenfant, C. (2010). Chest pain of cardiac and noncardiac origin. Metabolism: Clinical and Experimental, 59 Suppl 1, S41-6. https://doi.org/10.1016/j.metabol.2010.07.014
29. Lobo, S. A., & Fischer, S. (2021). Cardiac Risk Assessment. Complications in Anesthesia, 147–149. https://doi.org/10.1016/B978-1-4160-2215-2.50043-0
30. Matusik, P., Lelakowski, J., Malecka, B., Bednarek, J., & Noworolski, R. (2016). Management of Patients with Atrial Fibrillation: Focus on Treatment Options. Journal of Atrial Fibrillation, 9(3), 1450. https://doi.org/10.4022/jafib.1450
31. Mezzani, A., Hamm, L. F., Jones, A. M., McBride, P. E., Moholdt, T., Stone, J. A., Urhausen, A., & Williams, M. A. (2013). Aerobic exercise intensity assessment and prescription in cardiac rehabilitation: a joint position statement of the European Association for Cardiovascular Prevention and Rehabilitation, the American Association of Cardiovascular and Pulmonary Rehabilita. European Journal of Preventive Cardiology, 20(3), 442–467. https://doi.org/10.1177/2047487312460484
32. Mozos, I., & Caraba, A. (2015). Electrocardiographic Predictors of Cardiovascular Mortality. Disease Markers, 2015, 727401. https://doi.org/10.1155/2015/727401
33. O’Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E. J., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C., Fesmire, F. M., Franklin, B. A., Granger, C. B., Krumholz, H. M., … Zhao, D. X. (2013). 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology, 61(4), 485–510.
34. Rasekaba, T., Lee, A. L., Naughton, M. T., Williams, T. J., & Holland, A. E. (2009). The six-minute walk test: a useful metric for the cardiopulmonary patient. Internal Medicine Journal, 39(8), 495–501. https://doi.org/10.1111/j.1445-5994.2008.01880.x
35. Riccio, C. C., Gulizia, M. M. F. F. C., Colivicchi, F. F. F. C., Di Lenarda, A. F. F. C., Musumeci, G., Faggiano, P. M., Abrignani, M. G., Rossini, R., Fattirolli, F., Valente, S., Mureddu, G. F., Temporelli, P. L., Olivari, Z., Amico, A. F., Casolo, G. F. F., Fresco, C., Menozzi, A., & Nardi, F. F. F. (2017). ANMCO/GICR-IACPR/SICI-GISE Consensus Document: the clinical management of chronic ischaemic cardiomyopathy. European Heart Journal Supplements : Journal of the European Society of Cardiology, 19(Suppl D), D163–D189.
36. Roversi, S., & Fabbri, L. M. (2018). [Lung and heart interaction: chronic obstructive pulmonary disease and ischemic heart disease]. Giornale italiano di cardiologia (2006), 19(3), 153–160. https://doi.org/10.1714/2883.29073
37. Russell, S. D., Saval, M. A., Robbins, J. L., Ellestad, M. H., Gottlieb, S. S., Handberg, E. M., Zhou, Y., & Chandler, B. (2009). New York Heart Association functional class predicts exercise parameters in the current era. American Heart Journal, 158(4 Suppl), S24. https://doi.org/10.1016/J.AHJ.2009.07.017
38. Shiota, S., Naka, M., Kitagawa, T., Hidaka, T., Mio, N., Kanai, K., Mochizuki, M., Kimura, H., & Kihara, Y. (2021). Selection of Comprehensive Assessment Categories Based on the International Classification of Functioning, Disability, and Health for Elderly Patients with Heart Failure: A Delphi Survey among Registered Instructors of Cardiac Rehabilitation. Occupational Therapy International, 2021, 6666203. https://doi.org/10.1155/2021/6666203
39. Stamatouli, A., Bedoya, P., & Yavuz, S. (2020). Hypothyroidism: Cardiovascular Endpoints of Thyroid Hormone Replacement . In Frontiers in Endocrinology (Vol. 10). https://www.frontiersin.org/article/10.3389/fendo.2019.00888
40. Sylvia, L. G., Bernstein, E. E., Hubbard, J. L., Keating, L., & Anderson, E. J. (2014). Practical guide to measuring physical activity. Journal of the Academy of Nutrition and Dietetics, 114(2), 199–208. https://doi.org/10.1016/j.jand.2013.09.018
41. Tessler, J., & Bordoni, B. (2022). Cardiac Rehabilitation. StatPearls Publishing.
42. Tuncay, F. (2010). Kardiyopulmoner Rehabilitasyon Uygulanacak Hastada DeIerlendirme. Journal of Physical Medicine & Rehabilitation Sciences/Fiziksel Tup ve Rehabilitasyon Bilimleri Dergisi, 13.,
43. Wang, W.-E., Ho, R. L. M., Gatto, B., van der Veen, S. M., Underation, M. K., Thomas, J. S., Antony, A. B., & Coombes, S. A. (2021). Cortical dynamics of movement-evoked pain in chronic low back pain. The Journal of Physiology, 599(1), 289–305. https://doi.org/10.1113/JP280735
44. Yeldan, İ. (2018). Kardiyak Rehabilitasyonda Değerlendirme. In H. Harutoğlu (Ed.), Kardiyak Rehabilitasyon. Hipokrat Yayınevi.